News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
US Supreme Court
US Supreme Court
Week in Review, June 10–14
Bob Grant | Jun 14, 2013
Supreme Court says no patenting (natural) genes; brain-computer interfaces mimic motor learning in brain; regenerating finger tips; gene therapy goes deeper; NIH needs more diversity; cross-border collaboration
Supreme Court Nixes Patenting Human Genes
Dan Cossins | Jun 13, 2013
The Justices have decided that isolated sequences of human DNA are not eligible for patent protection, but rules that artificial sequences can be patented.
Supreme Court OKs DNA Collection on Arrest
Dan Cossins | Jun 4, 2013
Top justices rule that police have the right to take DNA swabs from people who are arrested, even before they are convicted.
Supreme Court Sides with Monsanto
Kate Yandell | May 15, 2013
The justices unanimously upheld Monsanto’s patent rights on Roundup Ready seeds.
Supreme Court Considers Gene Patents
Dan Cossins | Apr 16, 2013
A decision will not be reached until later in the year, but the United States’ top justices appear to be inclined to rule against the validity of patenting human genes.
Genetic Privacy for Suspects?
Dan Cossins | Feb 12, 2013
In an upcoming hearing, the US Supreme Court will decide on whether police can take DNA samples from suspects who have not been convicted.
Supreme Court Rejects Stem Cell Case
Jef Akst | Jan 8, 2013
The highest court in the country has declined to hear an appeal regarding the federal funding of human embryonic stem cell research, allowing such spending to continue.
hESC Opponents File with Supreme Court
Jef Akst | Oct 12, 2012
Scientists fighting the federal funding of human embryonic stem cell research bring their case before the country’s highest court.
Memory Not Reliable, Court Says
Cristina Luiggi | Jul 30, 2012
New Jersey judges are now required to explain to jurors that the human memory is prone to errors.
Watson Opposes Gene Patents
Jef Akst | Jul 19, 2012
James Watson files a brief in the ongoing legal case over Myriad Genetics’ right to hold patents on the BRCA1 and BRCA2 genes.